Download the study
The time to improve tumor site programs is now
Oncology programs are faced by surging demand: the number of new cancer cases in the U.S. is expected to grow by more than 25% over the next decade. At the same time, competition for these volumes has increased, and treatment innovations mean that cancer care is becoming more complex.
Tumor site programs, organized to help providers anticipate and meet patients’ diverse medical and psychosocial needs, are one response to these challenges. They can lead to higher quality, patient-centered care while also strengthening market strategy and supporting larger organizational goals. Read more about the importance of tumor site programs.
Programs of excellence for five tumor sites
Breast cancer programs are the most common type of tumor site program. This chapter breaks down topics including the impact changes to screening guidelines will have on mammography volumes, innovations in radiation therapy, and survivorship services. Read more.
Over the next ten years, organizations will see lung cancer incidence grow significantly. This chapter explores topics including nodule management, thoracic and cardiothoracic surgeon benchmarks, and palliative care. Read more.
Gynecologic cancers account for 11% of new cancer cases among women. This chapter focuses on topics such as how to evaluate if a gynecologic oncology program is a smart investment, tactics to increase access to subspecialists, and telehealth strategies. Read more.
Colorectal cancer incidence is on the rise. This chapter covers strategies to improve colorectal cancer screening rates and ways to support patients’ nutritional needs. Read more.
Prostate cancer is one of the most common cancers in the U.S. This chapter digs into topics including collaborating with independent urologists to treat patients, emerging diagnostic technologies, and robot-assisted radical prostatectomy. Read more.
